Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

NCT01581853 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Lopinavir/ritonavir 800 mg / 200mg

Sponsor

Daniel Podzamczer